Article info
PDFCommentary
Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
- Correspondence to Professor Rod S Taylor, MRC/CSO Social and Public Health Sciences Unit & Robertson Centre for Biostatistics, Institute of Health and Well Being, University of Glasgow, Glasgow, UK; rod.taylor{at}glasgow.ac.uk
Citation
Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
Publication history
- First published June 24, 2022.
Online issue publication
May 11, 2023
Article Versions
- Previous version (15 November 2022).
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.